NCT02946996 2026-03-05
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Medical University of South Carolina
Phase 2 Terminated
Clinical Trials
9 trialsNCT06884683 2025-03-19
NivoMet
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2 Terminated
NCT03031821 2024-10-04
PRIME
Canadian Urologic Oncology Group
Phase 3 Terminated
NCT01996696 2024-01-30
PREMIUM
AHS Cancer Control Alberta
Phase 2 Terminated
NCT02640534 2023-06-27
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone
Swiss Cancer Institute
Phase 2 Terminated
NCT02945813 2022-04-14
SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
Swiss Cancer Institute
Phase 2 Terminated
NCT02495103 2021-01-26
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT01215032 2017-05-15
Metformin in Castration-Resistant Prostate Cancer
Massachusetts General Hospital
Phase 2 Terminated
NCT00881725 2012-06-19
ANIMATE
University Health Network, Toronto
Phase 2 Terminated